These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3917946)

  • 21. Response of ovarian steroid secretion to the intrinsic gonadotropin release caused by the administration of synthetic luteinizing hormone-releasing hormone.
    Arai K; Yanaihara T; Okinaga S
    Am J Obstet Gynecol; 1975 Dec; 123(8):804-10. PubMed ID: 1106201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone, estradiol, and inhibin regulation of follicle-stimulating hormone and luteinizing hormone surges: implications for follicle emergence and selection in heifers.
    Haughian JM; Ginther OJ; Diaz FJ; Wiltbank MC
    Biol Reprod; 2013 Jun; 88(6):165. PubMed ID: 23658431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM; Lunn SF; Morris KD; Deghenghi R
    Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL; Casper RF; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycle.
    Monroe SE; Henzl MR; Martin MC; Schriock E; Lewis V; Nerenberg C; Jaffe RB
    Fertil Steril; 1985 Mar; 43(3):361-8. PubMed ID: 3156770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N; Olivier GC
    Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
    Sopelak VM; Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing the dynamics of gonadotropin response following bolus infusion of luteinizing hormone-releasing factor in women with menstrual abnormalities.
    Cantor B; Kalra PS; Buhi WC; Birk SA; Spellacy WN
    Fertil Steril; 1977 May; 28(5):526-30. PubMed ID: 323072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the effect of the therapeutic dosage of indomethacin on human gonadotropin secretion (author's transl)].
    Ofuji N
    Nihon Naibunpi Gakkai Zasshi; 1978 Jun; 54(6):787-800. PubMed ID: 352748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of a gonadotropin-releasing hormone antagonist to mares at different times during the luteal phase of the estrous cycle.
    Evans MJ; Alexander SL; Irvine CH; Kitson NE; Taylor TB
    Anim Reprod Sci; 2011 Sep; 127(3-4):188-96. PubMed ID: 21889856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LHRH and steroid levels in normal ovulatory women.
    Stone SC; Dickey RP; Kastin AJ; Schally AV
    Obstet Gynecol; 1976 Aug; 48(2):146-9. PubMed ID: 781572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of a controlled-release microcapsule formulation of an LH-RH agonist (D-Trp-6-LH-RH) in the rhesus monkey menstrual cycle.
    Asch RH; Rojas FJ; Tice TR; Schally AV
    Int J Fertil; 1985; 30(2):19-26. PubMed ID: 2865220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulsatile secretion of ovarian steroids in the mid-luteal phase of the menstrual cycle].
    Kajimura H
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):134-44. PubMed ID: 2110081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.